Position in NTRA
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$589,317
New position
Shares Held
2,171
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#506
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DARA CAPITAL US, INC. holds $3,955,394 across 8 Diagnostics & Research names. NTRA ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
6,390 | $1,217,167 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,893 | $949,074 | |
| 3 | NTRA |
Natera, Inc.
This page
|
2,171 | $589,317 | |
| 4 | A |
Agilent Technologies, Inc.
|
4,283 | $568,910 | |
| 5 | GH |
Guardant Health, Inc.
|
1,563 | $234,496 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,028 | $198,630 | |
| 7 | ILMN |
Illumina, Inc.
|
589 | $103,563 | |
| 8 | RVTY |
Revvity, Inc.
|
847 | $94,237 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $589,317 | 2,171 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||